1 terminated, 1 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
Follow Digestive System Carcinoma: new trials by email Literature Review of Digestive System Carcinoma trials Research Report on Digestive System Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal or Breast Cancer Lorcaserin, Lorcaserin Hydrochloride, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Withdrawn | Ohio State University Comprehensive Cancer Center | 2020-11-01 | 2021-01-19 | |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Bevacizumab, Cetuximab, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Castleman Disease | Phase 1 | Terminated | M.D. Anderson Cancer Center | 116 | 2012-10-16 | 2026-11-05 |
Breast Neoplasms (1) · Carcinoma, Transitional Cell (1) · Castleman Disease (1) · Endocrine Gland Neoplasms (1) · Erdheim-Chester Disease (1) · Lymphangioleiomyomatosis (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Mesothelial (1) · Neurofibromatosis 2 (1) · Pharyngeal Neoplasms (1) · Recurrence (1) · Sarcoma (1) · Soft Tissue Neoplasms (1)
Breast Diseases (1) · Carcinoma (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1) · Disease Attributes (1) · Ear Diseases (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Head and Neck Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Heredodegenerative Disorders, Nervous System (1) · Histiocytosis (1)
Bevacizumab (1) · Cetuximab (1) · Disulfides (1) · Immunoglobulin G (1) · Sirolimus (1) · Valproic Acid (1) · lorcaserin (1) · temsirolimus (1)
M.D. Anderson Cancer Center (1) · Ohio State University Comprehensive Cancer Center (1)
United States (1)
Maryam B Lustberg, MD (1) · Sarina A Piha-Paul (1)
PMID 26933802, PMID 37311055, PMID 41389341
P30CA016058 (1)